Search Results - "Linnet, Soeren"

Patients' preferences for subcutaneous trastuzumab versus conventional intravenous infusion for the adjuvant treatment of HER2-positive early breast cancer: final analysis of 488 patients in the international, randomized, two-cohort PrefHer study by Pivot, X., Gligorov, J., Müller, V., Curigliano, G., Knoop, A., Verma, S., Jenkins, V., Scotto, N., Osborne, S., Fallowfield, L., Fallowfield, Lesley, Jenkins, Valerie, Kilkerr, Justine, Langridge, Carolyn, Monson, Kathryn, Jakobsen, Erik Hugger, Nielsen, Mette Holck, Linnet, Soeren, Knoop, Ann, Pivot, Xavier, Bonnefoi, Herve, Mousseau, Mireille, Zelek, Laurent, Bourgeois, Hugues, Lefeuvre, Claudia Plesse, Bachelot, Thomas, Petit, Thierry, Brain, Etienne, Levy, Christelle, Gligorov, Joseph, Augustin, Doris, Graf, Heiko, Heinrich, Georg, Kroening, Hendrik, Kuemmel, Sherko, Müller, Volkmar, Overkamp, Friedrich, Park-Simon, Tjoung-Won, Schmidt, Marcus, Perlova-Griff, Lidia, Wolf, Christopher, Colleoni, Marco, Ballestrero, Alberto, Bernardo, Antonio, Ribecco, Angela Stefania, Gianni, Luca, Curigliano, Giuseppe, Brewczynska, Elżbieta, Jassem, Jacek, Shirinkin, Vadim, Manikhas, Alexey, Dvornichenko, Victoria, Lichinitser, Mikhail, Semiglazov, Vladimir, Mukhametshina, Guzel, Bulavina, Irina, Arranz, Enrique Espinosa, Ocon, Francisco Carabantes, Vivanco, Guillermo López, Bofill, Javier Salvador, Quintela, Ignacio Porras, Muñoz, Alfonso Sanchez, Pérez, Yolanda Fernández, Espinosa, Javier Cassinello, Alvarez, José Valero, del Prado, Rodrigo Lastra, De Merino, LuisLa Cruz, García, José Manuel Pérez, Frances, Santos Enrech, Edlund, Per, Norberg, Bengt, Wennstig, Anna-Karin, Lind, Pehr, Hauser, Nik, Tausch, Christoph, Camci, Celalettin, Arpaci, Fikret, Abali, Huseyin, Uslu, Ruchan, Tahir, Saad, Wheatley, Duncan, Chan, Stephen, Barrett-Lee, Peter, McAdam, Karen, Simcock, Richard, Burcombe, Russell, El-Maraghi, Robert, Califaretti, Nadia, Spadafora, Silvana, Sehdev, Sandeep, Sami, Amer, Verma, Sunil

“…Patients with HER2-positive early breast cancer (EBC) preferred subcutaneous (s.c.) trastuzumab, delivered via single-use injection device (SID), over the…”
Get full text

PO86 - Efficacy and Toxicity of Eribulin in Real-Life Non-Selected Advanced Breast Cancer Patients by Brems-Eskildsen, Anne Sofie, Kristoffersen, Kristina Bak, Linnet, Soeren, Lörincz, Tamás, Langkjer, Sven Tyge

Get full text

Efficacy and Toxicity of Eribulin in Real-Life Non-Selected Advanced Breast Cancer Patients by Brems-Eskildsen, Anne Sofie, Kristoffersen, Kristina Bak, Linnet, Soeren, Lörincz, Tamás, Langkjer, Sven Tyge

Get full text

Liposomal cisplatin response prediction in heavily pretreated breast cancer patients: A multigene biomarker in a prospective phase 2 study by Jakobsen, Erik Hugger, Nielsen, Dorte, Danoe, Hella, Linnet, Soeren, Hansen, Joergen, Lassen, Ulrik Niels, Balslev, Eva, Glavicic, Vesna, Bogovic, Jurij, Knudsen, Steen, Ejlertsen, Bent, Knoop, Ann Søegaard, Buhl, Ulla Hald, Madsen, Mogens Winkel, Buhl, Ida Kappel, Hansen, Anker, Jensen, Thomas, Rasmussen, Annie, Jensen, Peter Buhl, Langkjer, Sven Tyge

“…Abstract only…”
Get full text

Prediction of exemestane benefit in patients with advanced breast cancer based on diagnostic biopsy mRNA analysis by Christensen, Troels Dreier, Buhl, Anna Sofie Kappel, Christensen, Ib Jarle, Nelausen, Knud Mejer, Balslev, Eva, Knoop, Ann Søegaard, Brix, Eva Harder, Vestlev, Peter Michael, Ejlertsen, Bent, Kumler, Iben, Luczak, Adam, Langkjer, Sven Tyge, Linnet, Soeren, Jakobsen, Erik, Bogovic, Jurij Antonovic, Glavicic, Vesna, Buhl, Ulla Hald, Jensen, Peter Buhl, Knudsen, Steen, Nielsen, Dorte

“…Abstract only e12532 Background: Exemestaneis a steroidal aromatase inhibitor used in the treatment of postmenopausal patients with estrogen…”
Get full text

Retrospective-prospective blinded evaluation predicting efficacy of epirubicin by a multigene assay in advanced breast cancer within a Danish Breast Cancer Cooperative Group (DBCG) cohort by Buhl, Anna Sofie Kappel, Christensen, Troels Dreier, Christensen, Ib Jarle, Nelausen, Knud Mejer, Balslev, Eva, Knoop, Ann S., Brix, Eva, Svensson, Else, Glavicic, Vesna, Luczak, Adam, Langkjer, Sven Tyge, Linnet, Soeren, Jakobsen, Erik, Bogovic, Jurij, Ejlertsen, Bent, Rasmussen, Annie, Hansen, Anker, Knudsen, Steen, Nielsen, Dorte, Jensen, Peter Buhl

“…Abstract only 1071 Background: Epirubicin remains a cornerstone in the treatment of primary and advanced breast cancer. This study evaluated the predictive…”
Get full text